Abstract:Objective: To investigate the effect of prenatal dexamethasone on short-term outcomes and long-term neurological development in late preterm infants with twin pregnancy. Methods: A total of 315 pregnant women with twin pregnancy and their preterm infants who delivered in Peking University Third Hospital from January 2019 to December 2022 were retrospectively analyzed. The clinical data of pregnant women and preterm infants were collected. They were divided into non-medication group (93 pregnant women and 186 preterm infants), medication after 34 weeks group (123 pregnant women and 246 preterm infants), and medication before 34 weeks group (99 pregnant women and 198 preterm infants). Short-term outcomes of preterm infants were analyzed, including the incidence of neonatal respiratory distress syndrome (NRDS), wet lung, hypoglycemia, neonatal septicemia, intraventricular hemorrhage (IVH), bronchopulmonary dysplasia (BPD) and neonatal necrotizing enterocolitis (NEC). "Ages and Stages Questionnaire-Third Edition (ASQ-3) scale" was used to follow up the late neurological development of preterm infants at the corrected age of 6-54 months, and the level of neurological development was compared. Results: (1) General conditions: the gestational age at delivery in the non-medication group [36.1 weeks (35.6, 36.6 weeks)] was later than that in the medication after 34 weeks group [36.1 weeks (35.2, 36.4 weeks)] and medication before 34 weeks group [35.2 weeks (34.2, 36.2 weeks)] groups, and the differences were statistically significant (all P<0.05). After correcting for gestational age, there was no significant difference in birth weight among the three groups (H=3.808, P=0.149). There were no significant differences in gender and the proportion of small for gestational age among the three groups (all P>0.05). (2) Short-term outcome: the incidence of wet lung was 7.0% (13/186), 11.0% (27/246) and 16.2% (32/198) in the non-medication group, medication after 34 weeks group and medication before 34 weeks group, respectively, and the difference was statistically significant (P=0.018). There were no significant differences in the incidence rates of NRDS, hypoglycemia, sepsis, IVH, BPD, and NEC among the three groups (all P>0.05). Logistic regression analysis with gestational age and newborn birth weight as confounding factors showed that early gestational age (OR=0.884, 95%CI: 0.837-0.933, P<0.001) and increased incidence of selective intrauterine growth restriction type I (OR=2.967, 95%CI: 1.153-7.639, P=0.024) could both lead to an increased incidence of wet lung. (3) Long-term outcomes: a total of 109 pregnant women completed the follow-up, and 218 preterm infants with a corrected age of 6-54 months at the end of follow-up were enrolled, including 86 cases in the non-medication group, 66 cases in the medication after 34 weeks group, and 66 cases in the medication before 34 weeks group. There were no significant differences in the scores of communication, gross motor, fine motor, problem solving and personal-social among the three groups (all P>0.05). Conclusion: Prenatal administration of a single course of dexamethasone does not affect the neonatal birth weight and short-term outcomes of twin late preterm infants, and has no adverse effect on the neurological development of twin late preterm infants with a corrected age of 6-54 months.

The Effects of Maternal Prenatal Administration of Dexamethasone on Distortion Product Otoacoustic Emission Results of 84 Newborns

Changes in Maternal Glucose Metabolism after the Administration of Dexamethasone for Fetal Lung Development

[Effect of prenatal glucocorticoid therapy on hearing screening in premature infants]

The influence of prenatal dexamethasone administration before scheduled full-term cesarean delivery on short-term adverse neonatal outcomes: a retrospective single-center cohort study

Effects of antenatal dexamethasone administration in the infant: long-term follow-up

Adverse effects of prenatal dexamethasone exposure on fetal development

Associations Between Antenatal Corticosteroid Exposure and Neurodevelopment in Infants

Effects of ambient air pollution, fresh fruit and vegetable intakes as well as maternal psychosocial stress on the outcome of newborn otoacoustic emission hearing screening

Correlation Between Risk Factors of Hearing Lose and Results of Initial Hearing Screening in 1021 Neonates

[Effects of dexamethasone on short-term and long-term outcomes in late preterm infants with twin pregnancy: an observational study]

Prenatal Exposure to the Herbicide 2,4-D is Associated with Deficits in Auditory Processing During Infancy.

Multi-organ developmental toxicity and its characteristics in fetal mice induced by dexamethasone at different doses, stages, and courses during pregnancy

Prenatal Organophosphate Insecticide Exposure and Infant Sensory Function.

Prenatal Exposure to Multiple Pesticides is Associated with Auditory Brainstem Response at 9months in a Cohort Study of Chinese Infants.

Application of Distortion Product Otoacoustic Emission in Asphyxiated Neonates

Maternal side effects of prenatal dexamethasone therapy for fetal congenital adrenal hyperplasia

Effects of antenatal corticosteroids on fetal hemodynamics: a longitudinal study

Effect of dexamethasone on fetal heart rate variability, by non-invasive non-stress test tracing in preterm labour

Effects of Intra-Amniotic and Maternal Intramuscular Injection of Glucocorticoid on Fetal Lung Maturity and Blood Glucose Level in Women with Gestational Diabetes Mellitus

Longitudinal Development of Distortion Product Otoacoustic Emissions in Infants With Normal Hearing

Short-term effects of antenatal betamethasone on fetal cardiovascular and circulation status: A quasi-experimental observational (before-after) study